These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 9222642)
1. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2. Rothe H; O'Hara RM; Martin S; Kolb H Diabetologia; 1997 Jun; 40(6):641-6. PubMed ID: 9222642 [TBL] [Abstract][Full Text] [Related]
2. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Trembleau S; Penna G; Gregori S; Gately MK; Adorini L Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777 [TBL] [Abstract][Full Text] [Related]
3. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018 [TBL] [Abstract][Full Text] [Related]
4. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice. Walz M; Overbergh L; Mathieu C; Kolb H; Martin S Horm Metab Res; 2002 Oct; 34(10):561-9. PubMed ID: 12439784 [TBL] [Abstract][Full Text] [Related]
6. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes. Moritani M; Yoshimoto K; Ii S; Kondo M; Iwahana H; Yamaoka T; Sano T; Nakano N; Kikutani H; Itakura M J Clin Invest; 1996 Oct; 98(8):1851-9. PubMed ID: 8878437 [TBL] [Abstract][Full Text] [Related]
7. Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. Martin S; van den Engel NK; Vinke A; Heidenthal E; Schulte B; Kolb H J Autoimmun; 2001 Sep; 17(2):109-17. PubMed ID: 11591119 [TBL] [Abstract][Full Text] [Related]
8. Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice. Rothe H; Hibino T; Itoh Y; Kolb H; Martin S J Autoimmun; 1997 Jun; 10(3):251-6. PubMed ID: 9218751 [TBL] [Abstract][Full Text] [Related]
9. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337 [TBL] [Abstract][Full Text] [Related]
10. IL-12 plays a pathologic role at the inflammatory loci in the development of diabetes in NOD mice. Nitta Y; Kawamoto S; Tashiro F; Aihara H; Yoshimoto T; Nariuchi H; Tabayashi K; Miyazaki J J Autoimmun; 2001 Mar; 16(2):97-104. PubMed ID: 11247635 [TBL] [Abstract][Full Text] [Related]
11. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. Rothe H; Jenkins NA; Copeland NG; Kolb H J Clin Invest; 1997 Feb; 99(3):469-74. PubMed ID: 9022080 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice. Rabinovitch A; Suarez-Pinzon WL; Sorensen O J Autoimmun; 1996 Oct; 9(5):645-51. PubMed ID: 8933280 [TBL] [Abstract][Full Text] [Related]
13. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Weiss L; Zeira M; Reich S; Har-Noy M; Mechoulam R; Slavin S; Gallily R Autoimmunity; 2006 Mar; 39(2):143-51. PubMed ID: 16698671 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS; Balasa B; Davies JD; Sarvetnick N J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077 [TBL] [Abstract][Full Text] [Related]
15. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. Suarez-Pinzon WL; Mabley JG; Strynadka K; Power RF; Szabó C; Rabinovitch A J Autoimmun; 2001 Jun; 16(4):449-55. PubMed ID: 11437493 [TBL] [Abstract][Full Text] [Related]
16. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice. Zhang J; Huang Z; Sun R; Tian Z; Wei H J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068 [TBL] [Abstract][Full Text] [Related]
17. Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant. Hartmann B; Bellmann K; Ghiea I; Kleemann R; Kolb H Diabetologia; 1997 Aug; 40(8):902-9. PubMed ID: 9267984 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates. Martin S; Hibino T; Faust A; Kleemann R; Kolb H J Autoimmun; 1996 Oct; 9(5):637-43. PubMed ID: 8933279 [TBL] [Abstract][Full Text] [Related]
19. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity. Alleva DG; Johnson EB; Wilson J; Beller DI; Conlon PJ J Leukoc Biol; 2001 Mar; 69(3):440-8. PubMed ID: 11261792 [TBL] [Abstract][Full Text] [Related]
20. Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas. Rothe H; Ito Y; Kolb H J Mol Med (Berl); 2001 May; 79(4):190-7. PubMed ID: 11409710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]